Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Intellectual property

As a consequence of the review, authorization and oversight of COVID-19 drugs under the Regulations, manufacturers may benefit from intellectual property protections that are available in respect of a submission that results in an NOC.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-07-29

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data